DoD Melanoma Focused Program Award - Rare Melanomas

closed

The FY23 MRP FPA-RM is intended to support a multidisciplinary research program of at least two, but not more than three, distinct but complementary projects addressing an overarching question relevant to rare melanomas (see Figure 1 on the next page). Applications for FPA-RM may propose projects across the entire research spectrum (biology, etiology, prevention, diagnosis and detection, prognosis, treatment, and quality of life) and must address a critical unmet need relevant to rare melanomas (e.g., uveal, acral, mucosal, pediatric). Studies involving non-melanoma skin cancers are not allowed under the FY23 MRP. The key aspects of this award are: Overarching Question: FPA-RM applications must describe a unifying, overarching question that will be investigated by a set of research projects to address a critical unmet need relevant to rare melanoma research and/or patient care. The question may focus on one specific rare melanoma, or the question may be designed to address a critical unmet need that is relevant to multiple rare melanomas.

High